Choosing a TPA: What Corporate Health Programme Buyers Should Evaluate

An employer chooses an insurer and negotiates a premium, but the party its employees actually deal with when they fall ill is usually the third-party administrator (TPA). The TPA runs the cashless desk, authorises hospital admissions, processes claims, and answers the call at midnight when a family member is being admitted. To the employee, the TPA is the insurance, because it is the face of every interaction that matters.

That makes TPA quality one of the most consequential and least examined decisions in a corporate health programme. Buyers spend weeks negotiating premium and sum insured and minutes, if that, on who administers the claims, then spend the policy year fielding employee complaints about exactly that. TPAs are registered and regulated under the IRDAI (Third Party Administrators - Health Services) Regulations, 2016. This post is a buyer's framework for evaluating one properly, distinct from the broker-remuneration view of TPA accounts; here the question is simply which TPA will actually serve the workforce well, and how to tell before the policy starts rather than after it fails.

The first structural question is who administers the claims: the insurer's own in-house health-administration team, or an external independent TPA the insurer appoints.

The in-house model concentrates accountability. When the insurer administers its own claims, there is no interface between the risk-carrier and the claims-servicer, and no gap where a claim can stall while two organisations point at each other. The independent-TPA model brings specialisation and scale, since a dedicated TPA administers claims across many insurers and employers as its whole business, but it adds a party between the insurer and the member.

The buyer's influence over this varies with size. On a large corporate programme, the buyer can often express a TPA preference or at least be consulted, because the insurer wants the account. On a smaller programme, the TPA usually comes bundled with the insurer, and the buyer's real choice is exercised at the point of choosing the insurer. Either way, the buyer should know which TPA administers its programme and evaluate that specific administrator, rather than treating administration as an invisible back-office detail. The label, in-house or independent, matters less than the demonstrated performance of the actual desk.

The single most important TPA attribute is whether its cashless hospital network is deep in the places the workforce actually uses it. A magnificent national network is worthless to an employee whose nearest empanelled hospital is three cities away.

The evaluation is concrete and the buyer should insist on it: take the postcodes where employees live and work, and check the TPA's cashless network against them, hospital by hospital, in those specific locations. A distributed workforce in tier-2 and tier-3 towns needs network depth there, not just in the metros. A single-site employer needs depth around that site. The right question is never "how many hospitals are in the network" but "how many good hospitals are cashless near where my people are," and the answer differs sharply by TPA and by location.

The network is also not static. A network that looks deep at inception can thin during the year, so the buyer should ask not only what the network is today but how stable it has been and how the TPA handles a hospital leaving the cashless list mid-policy.

Cashless works only if authorisation is fast. An employee at a hospital admission desk waiting for the TPA to approve cashless is the moment the whole programme is judged, and a slow or uncertain authorisation turns a cashless promise into an out-of-pocket payment and a reimbursement fight.

IRDAI's health-insurance framework has pushed hard on this, setting expectations for rapid cashless decisions: authorisation of a cashless request within a short window of receiving it, and final authorisation at discharge within a few hours, so that patients are not held at the hospital waiting on the insurer. A buyer should ask each TPA for its actual turnaround performance against those expectations, not its promise, because the gap between the stated timeline and the delivered one is where employee experience is won or lost.

The forward-looking test is NHCX readiness. The National Health Claims Exchange (NHCX) is the shared digital rail intended to standardise and speed the exchange of claims information between hospitals, insurers and TPAs. A TPA that is genuinely integrated and processing through NHCX is positioned for faster, more standardised cashless settlement than one still running on bilateral, manual hospital interfaces. The buyer should ask where the TPA actually stands on NHCX integration, as a signal of both current capability and future direction.

Things go wrong in every programme; what separates a good TPA from a bad one is what happens when they do. A denied pre-authorisation on a genuine claim, a dispute over what is payable, an employee stuck at a hospital, these are the moments that define the relationship, and they need a clear escalation path and a human who owns the resolution.

The buyer should establish, before placing, how escalation works: is there a dedicated account manager for the corporate programme, or does every query go into the same retail queue as an individual policyholder; who does HR call when an employee is stuck; and how fast does a stuck case actually get resolved. A TPA that services a corporate programme through the same anonymous channel as a walk-in retail customer will fail the corporate buyer at exactly the escalation moments that matter. Dedicated corporate servicing, with named accountability, is a genuine differentiator and worth confirming rather than assuming.

Two operational capabilities separate a professional TPA from a struggling one, and both are invisible until they fail.

The first is data and MIS quality. A corporate buyer needs regular, accurate management information: claims incurred, claim ratios, the split between cashless and reimbursement, the conditions driving claims, and utilisation by employee band. This data is what lets a buyer manage the programme, understand its cost drivers, design wellness interventions and negotiate the renewal from evidence. A TPA that cannot produce clean, timely MIS leaves the buyer flying blind and negotiating the renewal on the insurer's numbers alone.

The second is float management. Where the employer funds claims through a cash-deposit or float arrangement, the TPA manages money that pays hospitals and reimburses employees. A TPA that manages the float poorly, letting it run dry, delaying hospital payments, holding up reimbursements, damages the programme directly: hospitals sour on the cashless arrangement and employees wait for their money. Float discipline is unglamorous and decisive, and a buyer should ask how the float is managed, how quickly reimbursements are paid, and whether hospitals in the network have had payment disputes with the TPA.

TPAs are paid either per member per period or as a percentage of premium, and the structure carries incentives worth understanding. A per-member fee ties the TPA's income to the population it services regardless of claims, which is cleaner. A percentage-of-premium fee ties it to premium, which can misalign as premium hardens. Neither is wrong, but the buyer should know which it is paying and what behaviour it rewards.

More important than the fee model are the red flags that predict a bad programme year, drawn from how these arrangements actually fail:

• Mid-year network shrinkage. Hospitals dropping off the cashless list during the policy year, often over payment disputes with the TPA, leaving employees who chose a hospital for its cashless status suddenly paying out of pocket. Ask about network stability, not just network size.
• Poor float management. Delayed hospital payments and slow reimbursements are a direct symptom, and they compound: unpaid hospitals de-empanel, which shrinks the network, which pushes more claims into reimbursement.
• A low cashless ratio. If a large share of claims end up as reimbursement rather than cashless, the TPA's network or authorisation is failing in practice whatever the brochure says.
• Weak or late MIS. A TPA that cannot report cleanly is a TPA the buyer cannot manage or hold accountable.
• Retail-queue servicing. No dedicated corporate desk means no accountability at the escalation moments that matter.

Bring the same rigour to the administrator that you bring to the premium.

1. Identify the actual TPA administering the programme, in-house or independent, and evaluate that specific desk rather than the label.
2. Test the cashless network against the postcodes where employees actually live, hospital by hospital.
3. Ask for the pre-authorisation turnaround and the cashless ratio, measured against IRDAI's cashless timelines, not the promise.
4. Ask where the TPA stands on NHCX integration.
5. Confirm the escalation path and whether there is a dedicated corporate account manager.
6. Demand a sample of the MIS the TPA will provide, and judge whether it is clean and timely.
7. Ask how the float is managed, how fast reimbursements are paid, and whether network hospitals have had payment disputes.
8. Understand the fee structure and the incentives it creates.

The premium and the sum insured are negotiated once a year; the TPA is experienced every day an employee needs care. A buyer that evaluates the administrator with the same rigour it brings to the premium, network fit, authorisation speed, NHCX readiness, escalation accountability, MIS and float discipline, buys a programme its workforce actually trusts. A buyer that treats the TPA as an invisible back office discovers its quality the hard way, one denied pre-authorisation at a time.